View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Chief Medical Officer Summit for Biotechs Goes West


  • June 18, 2013

  • After the successful launch of CMO East, The Conference Forum is thrilled to announce that Chief Medical Officers on the West Coast will have their own conference, November 4-5, 2013 at the Marines Memorial Club & Hotel.

    New York, NY, June 17, 2013

    With the huge success of CMO East, we are thrilled to announce the launch of the Chief Medical Officer Summit for Emerging Life Science Companies on the West Coast! CMO West will take place in San Francisco on November 4-5, 2013 at the Marines Memorial Club & Hotel.

    For the first time, West Coast Chief Medical Officers at biotechs have their own conference, thanks to the idea from Dr. Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the event organizer said, “We are grateful to Dr. Stoner’s idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs.”

    The Chief Medical Officer Summit West is dedicated to accomplishing two goals:

    1. To provide a forum to address the unique needs of Emerging Life Science Chief Medical Officers in de-risking drug development, selecting and managing CROs, leveraging capital to manage all R&D functions with limited resources, working more successfully with investors and strategizing for appropriate exits in the current environment.

    2. To create a network of Life Science CMOs to form a community that can shares ideas, solutions and support.

    Boston attendee Dominic J.F. Tong, MD said of the program, “It is a pleasure to have attended a historic meeting [of] the outstanding inaugural Chief Medical Officer Summit.”

    CMO West speaker Santosh Vetticaden, PhD, MD, CMO, SVP, Mast Therapeutics, Inc., said, “I found the East Coast meeting extremely useful since it was designed exclusively to addressing CMO interests. The opportunity to network with my peers at this event was invaluable since, barring this meeting, interactions I have with my peers tend to be at scientific meetings where the focus is the scientific meeting and not the CMO peer interactions.”

    About The Conference Forum:
    The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

    The Speaking Faculty: Full Biographies Available Here

    Srinivas Akkaraju, MD, PhD, General Partner, Sofinnova Ventures
    Lee Allen, MD, PhD, CMO, Spectrum Pharmaceuticals
    Zoran Antonijevic, Senior Director, Strategic Consulting and Adaptive Implementation, Cytel Inc.
    Mohammad Azab, MD, MBA, CMO, Astex Pharmaceuticals
    Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH
    Jill Carroll, Senior Associate, SR One
    Farah Champsi, MBA, Managing Director, Alta Partners
    Adam Craig, MD, PhD MBA, EVP, Development & CMO, Sunesis Pharmaceuticals, Inc.
    Howard Dittrich, MD, CMO, Sorbent Therapeutics
    Sheila Gujrathi, MD, CMO, Receptos, Inc.
    Barry Hafkin, MD, CMO, Affinium Pharmaceuticals
    Laurie Halloran, BSN, MS, President & CEO, Halloran Consulting Group, Inc.
    Julie Hambleton, MD, SVP & CMO, Five Prime Therapeutics
    M. Scott Harris, MD, CMO / Principal / Clinical Professor of Medicine, Avaxia Biologics, Inc. / Middleburg Consultants / Georgetown University School of Medicine
    Rekha Hemrajani, MBA, Vice President, Head of Licensing & M&A, Onyx Pharmaceuticals
    Jan Johansson, MD, PhD, SVP Medical Affairs, Resverlogix
    Jeff Jonker, Former Chief Business Officer, Satori Pharmaceuticals
    Lori Kunkel, MD, CMO, PCYC
    Jeffery Loutit, MBChB, CMO, Rempex Pharmaceuticals
    Jonathan MacQuitty, PhD, MBA, Partner, Abingworth
    Tyler Martin, MD, Former President, CMO & Director, Dynavax Technologies
    Nestor Molfino, MD, CMO, KaloBios
    Pamela Palmer, MD, PhD, CMO, AcelRx Pharmaceuticals, Inc.
    Hemai Parthasarathy, PhD, Scientific Director, Breakout Labs, The Thiel Foundation
    Carol Sands, Managing General Partner / Founder, The Halo Funds / The Angels’ Forum
    Tracy Saxton, PhD, Associate, SV Life Sciences
    Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience
    Jeffrey Sherman, MD, FACP, CMO & EVP, Development, Manufacturing and Regulatory Affairs, Horizon Pharma
    Stephen Shrewsbury, MD, MBChB, MRCGP, FCCP, FACAAI, FFPM, FAAAAI, SVP, Clinical Development & CMO, Aquinox Pharmaceuticals
    Michael Sweeney, MD, CMO & VP of R&D, Depomed
    Frank Torti, MD, Principal, NEA
    Santosh Vetticaden, MD, PhD, CMO, SVP, Mast Therapeutics, Inc.
    Samuel Wu, MD, PhD, Managing Director, MedImmune Ventures